Psychoanalytically oriented brief group treatment for borderline personality disorder: a randomised controlled trial

ISRCTN	ISRCTN79187618
DOI	https://doi.org/10.1186/ISRCTN79187618
Secondary identifying numbers	N0573173216

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr Ravi Lingam
Scientific

Regional Department of Psychotherapy
Claremont House
Off Framlington Place
Newcastle upon Tyne
NE2 4AA
United Kingdom

Phone	+44 (0)191 2824547
Email	Ravi.Lingam@nmht.nhs.uk

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Hospital
Study type	Treatment
Participant information sheet	Not available in web format, please use the contact details to request a patient information sheet
Scientific title	Psychoanalytically oriented brief group treatment for borderline personality disorder: a randomised controlled trial
Study objectives	Is psychoanalytically oriented brief group psychotherapy an effective treatment for borderline personality disorder?
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Mental and Behavioural Disorders: Borderline personality disorder
Intervention	The intervention to be researched is a Psychoanalytic Brief Group treatment, it is a 20-week outpatient programme. There are two treatment groups. Each group will consist of 8 subjects. The control will consist of a waiting list control. This will be treatment-as-usual for the subjects and will consist of their ongoing existing treatment in psychiatric or primary care services.
Intervention type	Behavioural
Primary outcome measure	Is a psychoanalytically-oriented brief group therapy an effective treatment for borderline personality disorder?
Secondary outcome measures	Reduction in self harm and suicidal ideation, reduction in symptoms and improvement in function and the cost implication of this treatment
Overall study start date	09/01/2006
Completion date	09/01/2008

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target number of participants	32
Key inclusion criteria	Clinical diagnosis of Borderline Personality Disorder meeting DSM-IV criteria and clinical judgment of capacity of psychological mindedness
Key exclusion criteria	Clinical risk assessment that there may be a significant acute risk of suicide or harm to others, that there is an active psychotic illness, or that there is use of alcohol or drugs to the extent that the subject cannot engage with the treatment.
Date of first enrolment	09/01/2006
Date of final enrolment	09/01/2008

Regional Department of Psychotherapy

Newcastle upon Tyne
NE2 4AA
United Kingdom

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Hospital/treatment centre

Northumberland, Tyne and Wear NHS Foundation Trust
Government organisation / Local government

NHS R&D Support Funding

No information available

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

10/07/2017: No publications found, verifying study status with principal investigator.